News

CureDiab present at ‘LifeScienceNet Düsseldorf meets BioCologne’
CureDiab present at ‘LifeScienceNet Düsseldorf meets BioCologne’
CureDiab at the BIO-Europe 2023
CureDiab at the BIO-Europe 2023
CureDiab at the Paris NASH Meeting 2023
CureDiab at the Paris NASH Meeting 2023
License contract signed
License contract signed
alytas therapeutics collaborates with CureDiab
alytas therapeutics collaborates with CureDiab
New shareholder structure
New shareholder structure
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!

Connect, follow and have a conversation with us

CMR CureDiab Metabolic Research GmbH
+49 172 2045992
contact@curediab.de
Merowingerplatz 1, 40225 Düsseldorf

© 2022 cureDiab All rights reserved

Services